People · Operator
Named in public records as an officer, director or promoter · active 2015–2026 · Pharmaceuticals, Healthtech, Other Energy, Other, Robotics, Media & Content
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Revalesio Corp | — | Pharmaceuticals | Series B | $103.4M | $624.1M | 2018 |
| Catapult Health, LLC | — | Healthtech | Series A | $27.7M | $52.2M | 2016 |
| XL Batteries, Inc. | — | Other Energy | Series A | $23.2M | $22.3M | 2024 |
| Apogee Acquisition Sponsor Llc | — | Other | Seed | $3.3M | $7.6M | 2026 |
| Cannon Workspace, LLC | — | Other | Seed | $3.0M | $56.7M | 2019 |
| Liquid Rarity Exchange LLC | — | Other | Seed | $2.2M | $21.1M | 2022 |
| GenZ Holdings Inc. | — | Other | Seed | $1.8M | $33.5M | 2019 |
| Texas Health Surgery Center Rockwall, LLC | — | Healthtech | Pre-Seed | $1.5M | $974K | 2026 |
| Riptide Autonomous Solutions, LLC | — | Robotics | Pre-Seed | $1.1M | $25.5M | 2015 |
| Vype Media, LLC | — | Media & Content | Pre-Seed | $625K | $13.0M | 2019 |
| Varsity Hype, Inc. | — | Other Technology | Pre-Seed | $295K | $6.9M | 2021 |
Jeffrey Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Toon | 3 | 4 |
| Shane Hildreth | 2 | 2 |
| John Mitchell | 1 | 23 |
| DeShon Woods | 1 | 14 |
| John Whiteley | 1 | 11 |
| Brandon Frazier | 1 | 11 |
| David Tamburri | 1 | 10 |
| Rebecca Tucker | 1 | 10 |
| Scott Thompson | 1 | 9 |
| Mark - Lester | 1 | 6 |
| Lee Huntsman | 1 | 5 |
| Krystal Mims | 1 | 5 |
| Barclay Berdan | 1 | 4 |
| Bill Linder | 1 | 4 |
| Saif Qazi | 1 | 4 |
| Scott Walchek | 1 | 4 |
| Jim Evely | 1 | 4 |
| Michael Theilmann | 1 | 2 |
| Gabriel Goncalves | 1 | 2 |
| David Michel | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.